The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
NCT00167882 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2006-09-11
Summary
The purpose of this study is to determine the influence of different 5-aminosalicylate concentrations on the metabolism of azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.
Conditions
Interventions
- DRUG
-
5-aminosalicylate (Pentasa, Ferring)
Sponsors & Collaborators
-
Amsterdam UMC, location VUmc
lead OTHER
Principal Investigators
-
K.H.N. de Boer, MD · Amsterdam UMC, location VUmc
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Completion
- 2006-08-31
Countries
- Netherlands
Study Locations
More Related Trials
-
The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
NCT02453607 ·Status: UNKNOWN
-
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
NCT03370601 ·Status: TERMINATED ·Phase: NA
-
Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
NCT05213234 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA
NCT05992142 ·Status: COMPLETED ·Phase: PHASE4
-
TP0502-Pharmaco-Scintigraphic-Study and Amendment
NCT02306785 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis
NCT00209287 ·Status: TERMINATED ·Phase: PHASE4
-
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
NCT01258205 ·Status: COMPLETED ·Phase: PHASE1
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Thiopurine Induced Pancreatitis in IBD Patients
NCT02281799 ·Status: WITHDRAWN ·Phase: PHASE4
-
AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease
NCT05452304 ·Status: COMPLETED ·Phase: PHASE1
-
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)
NCT00984568 ·Status: TERMINATED ·Phase: PHASE3
-
Addition of Azathioprine in IBD Patients With Immunogenic Failure
NCT03580876 ·Status: UNKNOWN ·Phase: PHASE4
-
The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD
NCT03393247 ·Status: UNKNOWN ·Phase: NA
-
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522 ·Status: RECRUITING ·Phase: PHASE2
-
TP0501 - Pharmaco-Scintigraphic-Study
NCT02306772 ·Status: COMPLETED ·Phase: PHASE1
-
Early Immunosuppressants in Crohn's Disease
NCT00546546 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
NCT05040464 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease
NCT00976690 ·Status: COMPLETED ·Phase: PHASE3
-
Mercaptopurine Therapy in Ulcerative Colitis
NCT02910245 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study With Pentasa in Patients With Active Crohn's Disease
NCT00862121 ·Status: TERMINATED ·Phase: PHASE3
-
Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients
NCT00774982 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
NCT01562951 ·Status: TERMINATED ·Phase: PHASE3
-
Azathioprine Linked With Impaired Intestinal Epithelial Postoperative Regeneration in Crohn's Disease
NCT05456776 ·Status: COMPLETED
-
Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery
NCT04160325 ·Status: RECRUITING ·Phase: NA